4Igari J,Watanabe M,Uehara N.Changes in the antibacterial activity of chemotherapeutic agents(especially carbapenems) for 10 species of clinical isolates between 1994 and 1996.Surveillance group ofthe sensitivities of clinical isolates to antibacterial agents[J].Jpn J Antibiot,2000,53(3):157. 被引量：1
5Suzuki Y,Nishinari C,Endo H.Antimicrobial activities of carbapenems and forth generation eephems against clinically isolated strains[J].Jpn J Antibiot,2001,54(9):473. 被引量：1
6Watanabe A,Tokue Y,Takahashi H,et al.In vitro activity of biapenem(BIPM)against clinically isolated respiratory pathogens in 1996-1998[J].Jpn J Antibiot,1999,52(12):690. 被引量：1
8Watanabe A,Tokue Y,Takahashi H,et al.In vitro activity of biapenem(BIPM)against clinically isolated respiratory pathogens in 1996-1998[J].Jpn J Antibiot,1999,52(12): 690. 被引量：1
9Basoli P,Meli A,Mazzocchi EZP,et al.Imipenem /cilastatin(1.5 g daily)versus meropenem (3.0 g daily) in patients with intra-ab-dominal infections:results of a prospective,randomized,multicen-tre trial[J].Scand J InfectDis,1997,29(5):503-508. 被引量：1
